COVID-19: Sputnik Light vaccine gets APPROVAL for phase 3 trial in India - Check details here
COVID-19 vaccine Sputnik Light has received the approval for phase 3 trial in India.
Sputnik Light COVID-19 Vaccine: There is some important development related to the COVID-19 vaccine scenario in India. COVID-19 vaccine Sputnik Light gets permission for phase 3 trials in India.
See Zee Business Live TV Streaming Below:
News agency ANI has tweeted about this latest development from its official Twitter handle. The tweet said, "COVID19 vaccine Sputnik Light gets permission for Phase 3 trials in India."
COVID19 vaccine Sputnik Light gets permission for Phase 3 trials in India pic.twitter.com/vPxjFz1Fs7
— ANI (@ANI) September 15, 2021
According to an ANI report, a Subject Expert Committee (SEC) meeting held on August 5, 2021 recommended the trial condition based on the efficacy of the vaccine was also to be evaluated on the 42nd, 90th and 180th day following the second dose.
The minutes of the SEC meeting reads, "Interim analysis can be conducted om day 42 as this data was generating during the Sputnik V trials in India after the first dose, which was stated to be available up to day 21," reported ANI.
Sputnik V was approved for 'emergency use' by the Drugs Controller General of India (DGCI) in the month of April. According the ANI report, Dr VK Paul, Member (Health), NITI Aayog informed that till now 8-9 lakh doses of Sputnik V have been administered in India.
Sputnik Light is the single dose variant of Sputnik V. It has to be noted that the Sputnik V COVID-19 vaccine has been developed by Russia's Gamaleya Institute with the assistance from Russian Direct Investment Fund (RDIF). RDIF entered into a partnership with Dr Reddy's Laboratories to market the Russian vaccine in India and also to conduct trails for the grant of required regulatory approvals. Sputnik V, the original two-dose composition has shown an efficacy of 79 per cent, informs ANI.
Speaking of the COVID-19 situation in India, as per the data released by the Ministry of Health and Family Welfare (MoHFW) on September 15, 2021, India recorded 27,176 new cases in the last 24 hours. Furthermore, 75.89 crore vaccine doses have been administered so far under Nationwide Vaccination Drive.
Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.
RECOMMENDED STORIES
Power of Compounding: How many years will it take to reach Rs 3 crore corpus if your monthly SIP is Rs 4,000, Rs 5,000, or Rs 6,000
Power of Compounding: Salary Rs 25,000 per month; is it possible to create over Rs 2.60 crore corpus; understand it through calculations
Reduce Home Loan EMI vs Reduce Tenure: Rs 75 lakh, 25-year loan; which option can save Rs 25 lakh and 64 months and how? Know here
Top 7 Large and Mid Cap Mutual Funds with Best SIP Returns in 5 Years: No. 1 fund has turned Rs 15,000 monthly SIP investment into Rs 20,54,384; know about others
New Year Pick by Anil Singhvi: This smallcap stock can offer up to 75% return in long term - Check targets
PSU Oil Stocks: Here's what brokerage suggests on these 2 largecap, 1 midcap scrips - Buy, Sell or Hold?
05:05 PM IST